Research Grants 307 show all


$40.8M
2015

$7.7M
2016

$18.3M
2017

$9.3M
2018

$6.5M
2019

Patents 870show all

  • 226
    A61K - Preparations for medical, dental, or toilet purposes
  • 145
    C07K - Peptides
  • 121
    C07D - Heterocyclic compounds
  • 76
    C12N - Microorganisms or enzymes
  • 59
    G01N - Investigating or analysing materials by determining their chemical or physical properties
  • 45
    C12Q - Measuring or testing processes involving enzymes, nucleic acids or microorganisms
  • 33
    A01K - Animal husbandry
  • 28
    C07C - Acyclic or carbocyclic compounds
  • 26
    B82Y - Specific uses or applications of nanostructures
  • 10
    C07H - Sugars

Publications 430 show all

  • 10
    Neoplasms/drug therapy
  • 9
    Antibodies, Neutralizing/immunology
  • 9
    HIV-1/immunology
  • 9
    Nanoparticles/adverse effects
  • 9
    Nanoparticles/chemistry
  • 8
    Estrogens/urine
  • 8
    Proto-Oncogene Proteins p21(ras)/metabolism
  • 6
    Estrogens/metabolism
  • 6
    HIV Antibodies/immunology
  • 6
    env Gene Products, Human Immunodeficiency Virus/immunology

Clinical Trials 137show all

31Phase 228Phase 319N/A18Phase 14Other

Contact Information

London, England
United Kingdom